1. Home
  2. ZBRA vs RDY Comparison

ZBRA vs RDY Comparison

Compare ZBRA & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zebra Technologies Corporation

ZBRA

Zebra Technologies Corporation

HOLD

Current Price

$265.70

Market Cap

13.7B

Sector

Industrials

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.06

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZBRA
RDY
Founded
1969
1984
Country
United States
India
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
11.6B
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
ZBRA
RDY
Price
$265.70
$14.06
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$346.29
$16.90
AVG Volume (30 Days)
622.0K
969.1K
Earning Date
10-28-2025
01-22-2026
Dividend Yield
N/A
0.51%
EPS Growth
34.78
9.95
EPS
9.93
0.79
Revenue
$5,255,000,000.00
$3,851,623,984.00
Revenue This Year
$10.26
$6.16
Revenue Next Year
$10.00
$2.57
P/E Ratio
$27.04
$17.83
Revenue Growth
12.87
14.10
52 Week Low
$205.73
$12.26
52 Week High
$427.76
$16.17

Technical Indicators

Market Signals
Indicator
ZBRA
RDY
Relative Strength Index (RSI) 53.26 53.57
Support Level $248.34 $13.97
Resistance Level $274.27 $14.16
Average True Range (ATR) 6.26 0.16
MACD 3.35 0.01
Stochastic Oscillator 71.31 78.76

Price Performance

Historical Comparison
ZBRA
RDY

About ZBRA Zebra Technologies Corporation

Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: